The numbers behind the mission — and why the world cannot afford to wait any longer for accessible vaccine innovation.
Vaccine-preventable diseases claim millions of lives annually in Africa — not because vaccines don't exist, but because systemic barriers make them impossible to access. Cold-chain failure, import dependency, and cost make effective immunization a privilege rather than a right.
Thermostable plant-derived antigens reduce or eliminate cold-chain requirements, enabling distribution to the most remote communities via community health worker networks.
Our platform is designed to be manufactured in African greenhouse facilities, creating local jobs, reducing import dependency, and strengthening national health security.
Plant-based bioprocessing generates 90% fewer carbon emissions than conventional fermentation-based manufacturing. We are building for both human and planetary health.